NEO:CCHW

Columbia Care Unveils New Name and Brand Identity – The Cannabist Company – to Bring Passion and People to the Forefront

Retrieved on: 
Tuesday, September 19, 2023
Marketing, Cannabis, Retail, Communications, Other Retail, Natural Resources, FSE, Creativity, Patient, NEO, NLRB v. Kentucky River Community Care, Inc., Cannabist Kansai

“The rebrand to The Cannabist Company marks an incredibly pivotal moment for us as an organization and speaks to where we are heading.

Key Points: 
  • “The rebrand to The Cannabist Company marks an incredibly pivotal moment for us as an organization and speaks to where we are heading.
  • Cannabist was launched in 2021 as the Company’s national retail brand, which now accounts for 36 locations across the country.
  • The Company will continue the process of converting its retail portfolio to the Cannabist brand across the country in 2024.
  • The Cannabist Company represents an opportunity to reintroduce ourselves in a way that combines our trusted heritage, passion for what we do, and the vision for where we are heading as a company and as an industry,” said Nicholas Vita, CEO, The Cannabist Company.

Columbia Care Announces Private Placement of US$25 Million and Executes on Next Phase of Balance Sheet Improvement Initiatives

Retrieved on: 
Monday, September 18, 2023
Other Manufacturing, Cannabis, Manufacturing, Biotechnology, Alternative Medicine, Health, Retail, Supply Chain Management, Natural Resources, Note, Indian stock exchange, Public company, FSE, Person, Sale, Convertible, US, Documentation, NLRB v. Kentucky River Community Care, Inc., NEO, Security (finance), Unit

In connection with the transaction, the Company and the investors entered into a customary registration rights agreement.

Key Points: 
  • In connection with the transaction, the Company and the investors entered into a customary registration rights agreement.
  • Completion of these transactions would be subject to definitive documentation and receipt of all necessary regulatory approvals.
  • The closing of the Initial Tranche is subject to customary closing conditions and is expected to close on or about September 21, 2023.
  • The Company intends to use the proceeds from the Offering to reduce its outstanding indebtedness and for general corporate purposes.

Columbia Care Announces Upcoming Conference Participation

Retrieved on: 
Monday, September 11, 2023
Other Manufacturing, Cannabis, Specialty, Manufacturing, Alternative Medicine, Health, Retail, Supply Chain Management, Natural Resources, International Life Sciences Institute, FSE, Conference, NEO, NLRB v. Kentucky River Community Care, Inc.

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that it will be participating in the following upcoming conferences:

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that it will be participating in the following upcoming conferences:
    ATB 2023 Life Sciences Institutional Investor Conference, New York, NY – September 20, 2023
    At each event, members of the management team will participate in fireside chats and host one-on-one investor meetings.
  • For additional information, please visit the Investor Relations section of the Company’s website at: https://investors.columbia.care .

Rosemary Mazanet, M.D., PhD. Joins Columbia Care's Board of Directors

Retrieved on: 
Monday, September 11, 2023
Natural Resources, Alternative Medicine, Other Manufacturing, Health, Specialty, Cannabis, Manufacturing, Retail, Columbia University, University of Southern California, Heart, Database, University, Palliative care, Wharton School of the University of Pennsylvania, Journal of Palliative Medicine, Coronavirus Scientific Advisory Board, General partnership, Human, FSE, National Institutes of Health, Bangladesh Technical Education Board, Dana–Farber Cancer Institute, Harvard Medical School, Tablet, Leonard Davis Institute of Health Economics, Journal, RAND Corporation, Clinical research, Internal medicine, Filgrastim, Knowledge, Hospital, FDA, Dana, NEO, NLRB v. Kentucky River Community Care, Inc., Chair, JAMA, Pharmaceutical industry, Management, Amgen, New York University, Brigham

Dr. Mazanet began advising Columbia Care in 2013 and then joined its Scientific Advisory Board as its Chair in 2015.

Key Points: 
  • Dr. Mazanet began advising Columbia Care in 2013 and then joined its Scientific Advisory Board as its Chair in 2015.
  • Since 2013, she has played an integral role of developing groundbreaking form factors specifically for palliative care, such as pressed tablets.
  • I know she will continue to add significant value as a member of our Board of Directors.
  • Congratulations, Rosemary and thank you," said Nicholas Vita, CEO, Columbia Care.

Columbia Care Reports Second Quarter 2023 Results

Retrieved on: 
Monday, August 14, 2023
Agriculture, Natural Resources, Pharmaceutical, Alternative Medicine, Health, Specialty, Cannabis, Retail, Note, Classix Nouveaux, Genetics, Telephone, Vita, Disclosure, Foot, Amber, Growth, Yoy, Seed, Adjustment, THC, Real estate, Video game, Security (finance)

[2]Excludes $36 thousand in Q2 2023, $0.6 million in Q1 2023 and $4.3 million in Q2 2022; see the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023 for additional disclosure.

Key Points: 
  • [2]Excludes $36 thousand in Q2 2023, $0.6 million in Q1 2023 and $4.3 million in Q2 2022; see the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023 for additional disclosure.
  • “Our second quarter results were solid, as we achieved more than $129 million in revenue, representing 4% sequential growth, confirming that we have kept our foot on the accelerator over the past 16 months.
  • We continued to reduce costs in the quarter, having now eliminated over $38 million, net, in annual expense, as we prioritize cash flow generation.
  • ET to discuss financial and operating results for the second quarter of 2023.

Columbia Care Continues Virginia Expansion with Opening of Cannabist Suffolk

Retrieved on: 
Wednesday, August 2, 2023
Alternative Medicine, Other Retail, Other Manufacturing, Health, Specialty, Manufacturing, Retail, Other Health, NLRB v. Kentucky River Community Care, Inc., Cannabis, Holland Road, Suite, City, Seed, FSE, Classix Nouveaux, NEO, Patient, Education

Cannabist Suffolk, located at 1238 Holland Road, Suite 111, is now serving registered medical patients.

Key Points: 
  • Cannabist Suffolk, located at 1238 Holland Road, Suite 111, is now serving registered medical patients.
  • This is the sixth Columbia Care retail location to open in Virginia within the past year.
  • “We’re thrilled to open Cannabist Suffolk and bring our award-winning Cannabist retail experience to those in the Suffolk region.
  • Cannabist Suffolk offers a variety of products such as flower, pre-rolls, edibles, and concentrates and carries Columbia Care brands including Classix, gLeaf, Hedy, and Seed & Strain.

Columbia Care to Report Second Quarter 2023 Results on August 14, 2023

Retrieved on: 
Tuesday, August 1, 2023
Biotechnology, Other Retail, Alternative Medicine, Online Retail, Manufacturing, Other Health, Health, Cannabis, Natural Resources, Other Manufacturing, Retail, Telephone, CSE, FSE, NEO, NLRB v. Kentucky River Community Care, Inc., EDT

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the second quarter ended June 30, 2023 before U.S. financial markets open on Monday, August 14, 2023.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the second quarter ended June 30, 2023 before U.S. financial markets open on Monday, August 14, 2023.
  • Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EDT to discuss financial and operating results for the second quarter of 2023.
  • After registering, instructions will be shared on how to join the call for those who wish to dial in.
  • A live audio webcast of the call will also be available in the Investor Relations section of the Company's website at https://investors.columbia.care/ or at https://edge.media-server.com/mmc/p/hhco3g37 .

Columbia Care Announces Date for Voluntary Delisting of Common Shares from CSE

Retrieved on: 
Tuesday, August 1, 2023
Biotechnology, Health, Natural Resources, Cannabis, Canada, NEO Exchange, CSE, FSE, Canadian Securities Exchange, NEO, NLRB v. Kentucky River Community Care, Inc., Security (finance)

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that, further to its press release dated July 31, 2023, it will voluntarily delist its common shares from the facilities of the Canadian Securities Exchange (“CSE”), effective as of market close on August 2, 2023.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that, further to its press release dated July 31, 2023, it will voluntarily delist its common shares from the facilities of the Canadian Securities Exchange (“CSE”), effective as of market close on August 2, 2023.
  • Columbia Care will continue trading on the Cboe Canada, the new business name of the NEO Exchange.
  • Cboe Canada will remain the Company’s primary securities exchange, as it has been since the Company’s initial public listing.
  • Management of the Company expects that focusing trading activity on a single, senior exchange will allow for a more orderly closing price formation and greater transparency for the Company and its investors.

Cresco Labs and Columbia Care Mutually Agree to Terminate Merger

Retrieved on: 
Monday, July 31, 2023
Cannabis, Natural Resources, Other Retail, Retail, Hemp, Partnership, Cresco Labs, CSE, Core, FSE, CL, Labs, NEO, Security (finance)

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”) and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”) today announced a mutual agreement, dated July 30, 2023, to amicably terminate the definitive arrangement agreement dated March 23, 2022, as amended on February 27, 2023, pursuant to which Cresco agreed to acquire all of the issued and outstanding shares of Columbia Care (the “Transaction”).

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”) and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”) today announced a mutual agreement, dated July 30, 2023, to amicably terminate the definitive arrangement agreement dated March 23, 2022, as amended on February 27, 2023, pursuant to which Cresco agreed to acquire all of the issued and outstanding shares of Columbia Care (the “Transaction”).
  • “In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders.
  • We want to express our sincere gratitude to Columbia Care for their valuable collaboration and dedication during this transaction,” said Charles Bachtell, CEO and Co-founder of Cresco Labs.
  • We are thankful for the collaboration and partnership with the Cresco team throughout this extensive process,” said Nicholas Vita, CEO and Co-founder of Columbia Care.

Columbia Care Announces Corporate Actions to Accelerate Operational Efficiencies and Cash Flow Generation

Retrieved on: 
Monday, July 31, 2023
Biotechnology, Health, Natural Resources, Cannabis, Canada, CSE, Canadian Securities Exchange, Marketing, NEO Exchange, Telephone, Vita, Tax, FSE, GAAP, Sale, EBITDA, NEO, NLRB v. Kentucky River Community Care, Inc., Bank, Security (finance), Mobile phone

“Over the past 16 months, we have implemented important changes to Columbia Care that have resulted in a stronger and more efficient company.

Key Points: 
  • “Over the past 16 months, we have implemented important changes to Columbia Care that have resulted in a stronger and more efficient company.
  • Over the next 12 months, we intend to launch a number of initiatives to further our goals of ongoing margin improvement, free cash flow generation, driving shareholder value and profitably capturing additional market share across the country,” said Nicholas Vita, CEO of Columbia Care.
  • These operational improvements are expected to be cash flow positive in 2023 and 2024.
  • Effective today, Columbia Care has named David Hart as President & Chief Operating Officer and Jesse Channon as Chief Commercial Officer.